» Articles » PMID: 34183870

Coculture of Primary Human Colon Monolayer with Human Gut Bacteria

Overview
Journal Nat Protoc
Specialties Biology
Pathology
Science
Date 2021 Jun 29
PMID 34183870
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of microbes in the colon impacts host physiology. Therefore, microbes are being evaluated as potential treatments for colorectal diseases. Humanized model systems that enable robust culture of primary human intestinal cells with bacteria facilitate evaluation of potential treatments. Here, we describe a protocol that can be used to coculture a primary human colon monolayer with aerotolerant bacteria. Primary human colon cells maintained as organoids are dispersed into single-cell suspensions and then seeded on collagen-coated Transwell inserts, where they attach and proliferate to form confluent monolayers within days of seeding. The confluent monolayers are differentiated for an additional 4 d and then cocultured with bacteria. As an example application, we describe how to coculture differentiated colon cells for 8 h with four strains of Bacteroides thetaiotaomicron, each engineered to detect different colonic microenvironments via genetically embedded logic circuits incorporating deoxycholic acid and anhydrotetracycline sensors. Characterization of this coculture system reveals that barrier function remains intact in the presence of engineered B. thetaiotaomicron. The bacteria stay close to the mucus layer and respond in a microenvironment-specific manner to the inducers (deoxycholic acid and anhydrotetracycline) of the genetic circuits. This protocol thus provides a useful mucosal barrier system to assess the effects of bacterial cells that respond to the colonic microenvironment, and may also be useful in other contexts to model human intestinal barrier properties and microbiota-host interactions.

Citing Articles

Development of a Caco-2-based intestinal mucosal model to study intestinal barrier properties and bacteria-mucus interactions.

Floor E, Su J, Chatterjee M, Kuipers E, Ijssennagger N, Heidari F Gut Microbes. 2024; 17(1):2434685.

PMID: 39714032 PMC: 11702969. DOI: 10.1080/19490976.2024.2434685.


A2-165 metabolizes host- and media-derived chemicals and induces transcriptional changes in colonic epithelium in GuMI human gut microphysiological system.

Huang Y, Lewis C, Wright C, Schneider K, Kemmitt J, Trumper D Microbiome Res Rep. 2024; 3(3):30.

PMID: 39421254 PMC: 11480719. DOI: 10.20517/mrr.2024.14.


Organoid modeling meets cancers of female reproductive tract.

Li J, Zhou M, Xie J, Chen J, Yang M, Ye C Cell Death Discov. 2024; 10(1):410.

PMID: 39333482 PMC: 11437045. DOI: 10.1038/s41420-024-02186-x.


In vitro co-culture models for studying organoids-macrophages interaction: the golden technology of cancer immunotherapy.

Liu J, Zhang B, Cui Y, Song H, Shang D Am J Cancer Res. 2024; 14(7):3222-3240.

PMID: 39113861 PMC: 11301299. DOI: 10.62347/BQFH7352.


Microfluidic gut-axis-on-a-chip models for pharmacokinetic-based disease models.

Kim R, Sung J Biomicrofluidics. 2024; 18(3):031507.

PMID: 38947281 PMC: 11210976. DOI: 10.1063/5.0206271.


References
1.
Trapecar M, Communal C, Velazquez J, Maass C, Huang Y, Schneider K . Gut-Liver Physiomimetics Reveal Paradoxical Modulation of IBD-Related Inflammation by Short-Chain Fatty Acids. Cell Syst. 2020; 10(3):223-239.e9. PMC: 8143761. DOI: 10.1016/j.cels.2020.02.008. View

2.
Noel G, Baetz N, Staab J, Donowitz M, Kovbasnjuk O, Pasetti M . A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions. Sci Rep. 2017; 7:45270. PMC: 5366908. DOI: 10.1038/srep45270. View

3.
McCracken K, Howell J, Wells J, Spence J . Generating human intestinal tissue from pluripotent stem cells in vitro. Nat Protoc. 2011; 6(12):1920-8. PMC: 3896236. DOI: 10.1038/nprot.2011.410. View

4.
Taketani M, Zhang J, Zhang S, Triassi A, Huang Y, Griffith L . Genetic circuit design automation for the gut resident species Bacteroides thetaiotaomicron. Nat Biotechnol. 2020; 38(8):962-969. PMC: 8922546. DOI: 10.1038/s41587-020-0468-5. View

5.
Riglar D, Giessen T, Baym M, Kerns S, Niederhuber M, Bronson R . Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation. Nat Biotechnol. 2017; 35(7):653-658. PMC: 5658125. DOI: 10.1038/nbt.3879. View